WHO stops tests on Trump-backed drug for Covid-19 use
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Geneva
TESTS of hydroxychloroquine, an anti-malaria drug touted by US President Donald Trump, were halted in a World Health Organization (WHO) trial of potential Covid-19 treatments.
The hydroxychloroquine arm of the WHO's Solidarity trial was stopped after advisers concluded that the drug shows no benefit compared to the standard of care in reducing deaths, WHO medical officer Ana Maria Henao-Restrepo said on Wednesday at a briefing in Geneva.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar